OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+56.76%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$466M
AUM Growth
+$466M
(+45%)
Cap. Flow
+$20.3M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
96.64%
Holding
16
New
1
Increased
4
Reduced
2
Closed
2
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$43.6M |
| 2 |
DERM
Dermira, Inc.
DERM
|
$18.5M |
| 3 |
AXDX
Accelerate Diagnostics
AXDX
|
$3.19M |
| 4 |
AMRN
Amarin Corp
AMRN
|
$519K |
| 5 |
Soleno Therapeutics
SLNO
|
$269K |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$35M |
| 2 |
Pacific Biosciences
PACB
|
$10.5M |
| 3 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$304K |
| 4 |
CFRX
ContraFect Corporation
CFRX
|
$39.2K |
Sector Composition
| 1 | Healthcare | 96.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
QuidelOrtho
QDEL
$1.95B
| $125M | 26.52% | 1,903,558 | – | – |
|
|
AMRN
2
Amarin Corp
AMRN
$311M
| $109M | 23.09% | 5,226,580 +25,000 | +0.5% | +$519K |
|
|
AXDX
3
DELISTED
Accelerate Diagnostics
AXDX
| $91.4M | 19.45% | 4,349,563 +151,541 | +4% | +$3.19M |
|
|
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $52.6M | 11.19% | 1,021,392 +846,857 | +485% | +$43.6M |
|
|
DERM
5
DELISTED
Dermira, Inc.
DERM
| $18.5M | 3.94% | +1,367,436 | New | +$18.5M |
|
|
BIOL
6
DELISTED
Biolase, Inc.
BIOL
| $14.7M | 3.13% | 6,173,250 | – | – |
|
|
VRML
7
DELISTED
Vermillion, Inc.
VRML
| $11.3M | 2.4% | 9,825,289 | – | – |
|
|
MOTS
8
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $10.8M | 2.3% | 2,775,000 | – | – |
|
9
Opko Health
OPK
$1.1B
| $9.62M | 2.05% | 3,686,194 | – | – |
|
|
10
Pacific Biosciences
PACB
$393M
| $8.03M | 1.71% | 1,110,666 -1,447,098 | -57% | -$10.5M |
|
|
11
Soleno Therapeutics
SLNO
$3.6B
| $7.86M | 1.67% | 3,813,558 +130,363 | +4% | +$269K |
|
|
AGEN
12
Agenus
AGEN
$133M
| $4.04M | 0.86% | 1,358,918 | – | – |
|
|
CFRX
13
DELISTED
ContraFect Corporation
CFRX
| $2.24M | 0.48% | 5,621,199 -98,573 | -2% | -$39.2K |
|
14
Biogen
BIIB
$19.4B
| $1.51M | 0.32% | 6,368 | – | – |
|
|
ADAP
15
Adaptimmune Therapeutics
ADAP
$15.6M
| – | – | -52,921 | Closed | -$304K |
|
|
TSRO
16
DELISTED
TESARO, Inc.
TSRO
| – | – | -471,500 | Closed | -$35M |
|